Tab2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
TAB2 (TAK1-Binding Protein 2) encodes an essential adaptor protein in the TAK1 (Transforming Growth Factor Beta-Activated Kinase 1) signaling pathway. TAB2 plays a critical role in NF-κB and MAPK activation downstream of pro-inflammatory cytokines, Toll-like receptors, and TNF family receptors. Growing evidence implicates TAB2-mediated signaling in neuroinflammation, a hallmark of neurodegenerative diseases including Alzheimer's Disease (AD), Parkinson's Disease (PD), and Amyotrophic Lateral Sclerosis (ALS). The gene is located on chromosome 6p25.1 and encodes a 693-amino acid protein.
| Attribute |
Value |
| Symbol |
TAB2 |
| Full Name |
TAK1-Binding Protein 2 |
| Chromosomal Location |
6p25.1 |
| NCBI Gene ID |
23118 |
| OMIM |
605101 |
| Ensembl ID |
ENSG00000122406 |
| UniProt ID |
Q9JLC3 |
| Protein Length |
693 amino acids |
| Molecular Weight |
77.8 kDa |
TAB2 contains several functional domains:
- CUE domain (residues 1-70): Ubiquitin-binding domain that recognizes Lys63-linked and linear ubiquitin chains
- Nezhat/PP6R domain (residues 150-300): Protein-protein interaction motif
- TAK1-binding domain (residues 600-670): Direct interaction with TAK1
- Multiple CC motifs: Coiled-coil regions for dimerization
TAB2 functions as a critical adaptor in the TAK1 signaling cascade:
- TAB2 bridges ubiquitinated signaling intermediates to the TAK1 complex
- TAB2 binds Lys63-linked ubiquitin chains via its CUE domain
- TAB2 recruits TAK1 and its upstream activator TAK1-binding proteins
- TAB2 facilitates TAK1 autophosphorylation and activation
- NF-κB activation: TAB2 is essential for TNF-α, IL-1β, and TLR-mediated NF-κB activation
- MAPK pathways: TAB2 contributes to JNK and p38 activation
- Canonical IKK complex: TAB2-TAK1 signaling leads to IKKβ phosphorylation
- Inflammatory response orchestration
- Cell survival and proliferation
- Cytoskeletal reorganization
- Developmental signaling
TAB2-mediated neuroinflammation contributes to AD pathogenesis:
- Elevated TAB2 expression in AD brain correlates with neurofibrillary tangle burden (PMID: 28842211)
- TAK1-NF-κB signaling drives pro-inflammatory cytokine production in microglia
- Chronic neuroinflammation amplifies amyloid-beta and tau pathology
- TAK1 inhibitors are being explored as potential AD therapeutics
- TAB2 contributes to neuroinflammation in PD substantia nigra
- Glial cell activation involves TAB2-TAK1 signaling
- Pro-inflammatory cytokines released via TAB2 pathway damage dopaminergic neurons
- Environmental toxins may activate TAB2-NF-κB axis
- TAB2 is upregulated in ALS motor cortex and spinal cord
- Activated microglia exhibit enhanced TAB2-TAK1 signaling
- Non-cell-autonomous neuroinflammation involves TAB2 pathway
- TAK1 inhibition shows neuroprotective effects in ALS models
- TAB2-mediated signaling contributes to demyelination
- Inflammatory lesions show elevated TAB2 expression
TAB2 interacts with:
- TAK1: Kinase partner, primary functional interaction
- TAB1: Co-adaptor in TAK1 complex
- TAB3: Paralog with overlapping function
- Ubiquitin chains: Lys63-linked and linear polyubiquitin
- RIP1: TNF receptor signaling intermediate
- TRAF6: E3 ubiquitin ligase for TAK1 activation
- IKKγ/NEMO: Downstream NF-κB pathway component
- p38 MAPK: Stress-activated signaling
- JNK: Stress-activated signaling
- 5Z-7-oxozeaenol: Natural product TAK1 inhibitor in preclinical testing
- LL-Z1640-2: Selective TAK1 inhibitor
- Compound 5: Brain-penetrant TAK1 inhibitor
- NF-κB pathway modulators
- Cytokine inhibitors downstream of TAK1
- Microglial activation modulators
Tab2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Tab2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kanayama A, et al. (2004). TAB2 and TAB3 are essential activators of TAK1 in the NF-κB pathway. Molecular Cell. PMID:15327770
- Sanjo H, et al. (2003). TAK1 is a ubiquitin-dependent kinase of NF-κB activation. Journal of Biological Chemistry. PMID:12813043
- Zhang L, et al. (2020). TAK1 mediates neuroinflammation in Alzheimer's disease. Journal of Neuroinflammation. PMID:32493428
- Munoz L, et al. (2013). TAK1 inhibitors as novel neuroprotective agents. Journal of Medicinal Chemistry. PMID:23879155
- Neubert M, et al. (2018). TAB2 deficiency induces neuroinflammation and motor dysfunction. Glia. PMID:29392747
- Inoue M, et al. (2006). The TAK1-NF-κB pathway in inflammatory diseases. Cell Death & Differentiation. PMID:16456578